NCT07294443

Brief Summary

Objective: This study was conducted to examine the effect of Qigong relaxation exercises applied in a psychiatric clinic on the anxiety and depression levels of patients diagnosed with depression. Design: This study was designed as a single-blind, randomized controlled trial. Research Hypotheses H1: State anxiety levels are lower in patients who perform Qigong exercises than in those who do not. H2: Depression levels are lower in patients who perform Qigong exercises than in those who do not. The study population consisted of 140 individuals aged 18 years and older diagnosed with depression who were hospitalized at a private psychiatric hospital in Turkey between March 1 and September 1, 2025. In the sample selection, the STAI-I and Beck Depression Scale were administered to the patients by the researchers. Since differences in anxiety and depression levels would affect group homogeneity, patients who scored below 35 on the STAI-I (mild and moderate levels) and between 17 and 30 on the Beck Depression Scale constituted the study sample. The study sample consisted of 70 patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 8, 2025

Last Update Submit

December 8, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Beck Depression Scale

    Beck Depression Scale: The Beck Depression Scale was used to measure the level and severity of depressive symptoms. The Beck Depression Scale, which underwent a Turkish validity and reliability study by Hisli in 1988, is a depression rating scale consisting of 21 questions. Individuals mark the statement that best describes how they have felt over the past 15 days, and the total score is calculated by summing the points (0-3) obtained from each response. According to the corresponding score ranges, the scale is evaluated as follows: 1-10 is normal, 11-16 is moderate mood disorder, 17-20 is clinical depression, 21-30 is moderate depression, 31-40 is severe depression, and 41-63 is major depression.

    6 weeks

  • State-Trait Anxiety Inventory

    This scale was developed by Spielberger et al. (1983), and its validity and reliability in Turkish were established by Öner and Le Compte (1985). The scale consists of two parts: the State Anxiety Scale (STAI-I) and the Trait Anxiety Scale (STAI-II). STAI-I examines how an individual feels at a specific time and under specific conditions, while STAI-II determines how an individual feels independently of the situation and conditions they are in. STAI-I form, which consists of 20 statements, was used to measure state anxiety. Respondents rated their level of anxiety on a 4-point (1- 4) intensity scale from not at all tovery much so.

    6 weeks

Study Arms (2)

QRE

EXPERIMENTAL
Other: Qigong relaxation exercises

Control group

ACTIVE COMPARATOR
Other: Ongoing treatment

Interventions

Qigong relaxation exercise is a type of exercise consisting of graceful body movements and relaxation, performed in harmony with breathing and meditation, aimed at relaxing the body and mind, reducing stress, diverting attention away from negative thoughts, accelerating blood flow, and improving emotions.

QRE

The control group's ongoing treatment continued.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient is literate
  • No communication barriers
  • The patient is receiving inpatient treatment at a psychiatric clinic
  • The patient has been diagnosed with depression
  • The patient is over 18 years of age
  • The patient is oriented to the service (at least 24 hours have passed since admission)
  • The patient regularly participates in Qigong practice

You may not qualify if:

  • The patient has communication difficulties
  • The patient has acute psychotic symptoms
  • The patient is receiving anxiolytic treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Sciences University

Istanbul, Üsküdar - Selimiye, 34668, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety DisordersDepressionMental Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

December 8, 2025

First Posted

December 19, 2025

Study Start

March 1, 2025

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations